American Healthcare REIT's (AHR) Hold (C) Rating Reiterated at Weiss Ratings

Key Points

• Weiss Ratings has reiterated a "hold (C)" rating for American Healthcare REIT (NYSE:AHR), reflecting a cautious outlook despite recent favorable ratings from other analysts.
• American Healthcare REIT's shares decreased by 1.2% to $40.55, with a significant market cap of $6.84 billion and a P/E ratio of -184.41.
• The company recently reported a quarterly earnings per share (EPS) of $0.42, beating expectations and showing a year-over-year revenue increase of 7.5%.

American Healthcare REIT (NYSE:AHR - Get Free Report)'s stock had its "hold (c)" rating restated by Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Several other equities research analysts also recently weighed in on the stock. Scotiabank restated an "outperform" rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Baird R W upgraded shares of American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Royal Bank Of Canada raised their target price on shares of American Healthcare REIT from $39.00 to $45.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Morgan Stanley restated an "overweight" rating on shares of American Healthcare REIT in a research note on Wednesday, September 3rd. Finally, Truist Financial raised their target price on shares of American Healthcare REIT from $44.00 to $46.00 and gave the company a "buy" rating in a research note on Tuesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $44.11.

American Healthcare REIT Stock Down 1.2%

Shares of NYSE AHR traded down $0.50 during midday trading on Wednesday, reaching $40.55. 348,268 shares of the company's stock traded hands, compared to its average volume of 1,607,709. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.41. The stock's 50 day simple moving average is $41.57 and its 200-day simple moving average is $36.51. American Healthcare REIT has a one year low of $23.66 and a one year high of $43.52. The company has a market cap of $6.84 billion, a price-to-earnings ratio of -184.41, a P/E/G ratio of 2.10 and a beta of 0.98.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The firm had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. During the same period last year, the firm earned $0.33 earnings per share. The company's quarterly revenue was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. On average, analysts predict that American Healthcare REIT will post 1.41 EPS for the current fiscal year.

Insider Activity

In related news, EVP Mark E. Foster sold 3,850 shares of the firm's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the transaction, the executive vice president owned 59,100 shares of the company's stock, valued at $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its position in shares of American Healthcare REIT by 22.1% during the 2nd quarter. GAMMA Investing LLC now owns 1,716 shares of the company's stock valued at $63,000 after buying an additional 311 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in shares of American Healthcare REIT by 1.4% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 29,300 shares of the company's stock valued at $1,086,000 after buying an additional 393 shares during the period. California State Teachers Retirement System raised its position in shares of American Healthcare REIT by 0.3% during the 2nd quarter. California State Teachers Retirement System now owns 140,769 shares of the company's stock valued at $5,172,000 after buying an additional 406 shares during the period. Lion Street Advisors LLC raised its position in shares of American Healthcare REIT by 6.2% during the 2nd quarter. Lion Street Advisors LLC now owns 7,373 shares of the company's stock valued at $271,000 after buying an additional 430 shares during the period. Finally, Benjamin Edwards Inc. raised its position in shares of American Healthcare REIT by 3.2% during the 1st quarter. Benjamin Edwards Inc. now owns 14,368 shares of the company's stock valued at $435,000 after buying an additional 444 shares during the period. Hedge funds and other institutional investors own 16.68% of the company's stock.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.